Answers are grounded in this paper and cite their sources.
No effective treatment has been demonstrated for patients with acute transverse myelopathy. In a multicentre controlled study, 12 children with severe acute transverse myelopathy were treated with intravenous methylprednisolone (IVMP) and compared with a historical group of 17 patients. The treatment had a significant effect on the proportion of patients walking independently at 1 month and on the proportion with full recovery at 1 year, with no differences in the frequency of complications between the two groups.
No takes yet. Share an insight, caveat, or question.
Pierre Defresne (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: